957205-23-1 Usage
Description
[4-cyclohexyl-3-(trifluoromethyl)phenyl]methanol is a complex organic compound characterized by a cyclohexyl group attached to a trifluoromethylphenyl moiety, with a hydroxymethyl group completing the structure. This unique arrangement of functional groups endows it with specific chemical properties that make it a valuable component in various applications, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
[4-cyclohexyl-3-(trifluoromethyl)phenyl]methanol is used as a pharmaceutical intermediate for the synthesis of various medicinal compounds. Its unique structure allows it to serve as a building block in the development of drugs targeting specific biological pathways or receptors, potentially leading to the creation of novel therapeutic agents.
As a pharmaceutical intermediate, [4-cyclohexyl-3-(trifluoromethyl)phenyl]methanol plays a crucial role in the synthesis of drugs with diverse therapeutic applications. Its cyclohexyl and trifluoromethylphenyl components can be strategically modified to enhance the drug's efficacy, selectivity, and pharmacokinetic properties, making it a versatile component in the medicinal chemistry toolkit.
Check Digit Verification of cas no
The CAS Registry Mumber 957205-23-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,2,0 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 957205-23:
(8*9)+(7*5)+(6*7)+(5*2)+(4*0)+(3*5)+(2*2)+(1*3)=181
181 % 10 = 1
So 957205-23-1 is a valid CAS Registry Number.
957205-23-1Relevant articles and documents
AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE
-
, (2021/10/15)
Relating to a compound represented by formula (I) and a pharmaceutically acceptable salt of the compound, and an application of the compound as an S1P1 agonist.
AZETIDINE MODULATORS OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR
-
, (2017/08/01)
Described are deuterium-substituted azetidine compounds of Formula (I), which are modulators of sphingosine 1 -phosphate receptor. Also described are pharmaceutical compositions comprising the deuterium-substituted azetidine compounds, and methods of use thereof.
Immunosuppressant Compounds and Compositions
-
Page/Page column 10; 11, (2008/06/13)
The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
